| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |